PHI with Urolithiasis

Read in German: PKV mit Urolithiasis

How does this condition affect your private health insurance?

Urolithiasis, commonly known as kidney stones, involves the formation of hard deposits of minerals and salts within the urinary tract. These stones can develop in the kidneys, ureters, bladder, or urethra. Symptoms typically include severe flank pain (renal colic), hematuria (blood in urine), nausea, vomiting, and frequent, painful urination, especially when a stone obstructs urine flow. Causes often involve dehydration, dietary factors, genetics, and metabolic abnormalities. If left untreated, urolithiasis can lead to urinary tract infections, hydronephrosis, and permanent kidney damage. Treatment ranges from conservative management for small stones to medical expulsive therapy, lithotripsy, or surgical removal for larger or obstructive stones. Prevention focuses on hydration and dietary modifications.

PKV Risk Assessment

High Probability of Rejection

However, some specialized PHI providers may insure you with a surcharge of up to 15%.

This is a preliminary assessment. For a detailed and binding risk assessment, .

Impact on Your Insurance Policy

Duration of Illness (Initial)

Days to several weeks (for stone passage or intervention).

Duration of Illness (Lifetime)

Often recurrent; can be a chronic condition with multiple episodes over a lifetime.

Cost of Treatment (Initial)

Varies from $500 (conservative) to $15,000+ (surgical intervention) in the US.

Cost of Treatment (Lifetime)

Can range from a few thousand to tens of thousands of dollars due to recurrence, follow-up, and potential complications.

Mortality Rate

Low (<1%) in uncomplicated cases; higher (5-10%) if severe sepsis or irreversible kidney damage occurs.

Risk of Secondary Damages

Moderate (10-30%) for potential kidney damage (e.g., hydronephrosis, infection, loss of function) or chronic pain, especially with recurrent or untreated stones.

Probability of Full Recovery

High (70-90%) from an acute episode if treated successfully, but there is a high risk of recurrence (up to 50% within 5-10 years).

Underlying Disease Risk

Moderate (20-40%) for associated metabolic disorders (e.g., hyperparathyroidism, gout, obesity, diabetes) or anatomical abnormalities contributing to stone formation.

The information provided is for general informational purposes only and is not a substitute for professional medical or insurance advice. Always consult with a qualified professional for any health concerns or before making any insurance decisions.